Terns Pharmaceuticals (TERN) had the highest return between August 8, 2022 and September 30, 2022 by a small-cap US stock, returning 161.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Terns Pharmaceuticals (TERN) | 8/8/2022 - 9/30/2022 | 161.78% |
Astria Therapeutics (ATXS) | 8/8/2022 - 9/30/2022 | 88.33% |
Larimar Therapeutics (LRMR) | 8/8/2022 - 9/30/2022 | 88.24% |
EVI Industries (EVI) | 8/8/2022 - 9/30/2022 | 85.67% |
Enliven Therapeutics (ELVN) | 8/8/2022 - 9/30/2022 | 85.37% |
Prothena (PRTA) | 8/8/2022 - 9/30/2022 | 82.79% |
Harrow Health (HROW) | 8/8/2022 - 9/30/2022 | 77.5% |
89bio (ETNB) | 8/8/2022 - 9/30/2022 | 58.63% |
NRx Pharmaceuticals (NRXPW) | 8/8/2022 - 9/30/2022 | 56.52% |
Phathom Pharmaceuticals (PHAT) | 8/8/2022 - 9/30/2022 | 52.83% |
Viridian Therapeutics (VRDN) | 8/8/2022 - 9/30/2022 | 49.82% |
Wave Life Sciences (WVE) | 8/8/2022 - 9/30/2022 | 47.95% |
Applied Opt (AAOI) | 8/8/2022 - 9/30/2022 | 45.45% |
Pulse Biosciences (PLSE) | 8/8/2022 - 9/30/2022 | 39.39% |
Limbach (LMB) | 8/8/2022 - 9/30/2022 | 35.96% |
InnovAge (INNV) | 8/8/2022 - 9/30/2022 | 35.17% |
Sigma Lithium Resources (SGML) | 8/8/2022 - 9/30/2022 | 33.22% |
Aquestive Therapeutics (AQST) | 8/8/2022 - 9/30/2022 | 32.95% |
Ardelyx (ARDX) | 8/8/2022 - 9/30/2022 | 32.38% |
TSS, Inc Common Stock (TSSI) | 8/8/2022 - 9/30/2022 | 30.87% |
Capricor Therapeutics (CAPR) | 8/8/2022 - 9/30/2022 | 30.43% |
Arena (AREN) | 8/8/2022 - 9/30/2022 | 30.02% |
Cricut (CRCT) | 8/8/2022 - 9/30/2022 | 28.61% |
Bright Minds Biosciences (DRUG) | 8/8/2022 - 9/30/2022 | 28.13% |
LSI Industries (LYTS) | 8/8/2022 - 9/30/2022 | 27.67% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
